Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters

Two Indian drugmakers to end trials of generic Merck pill for moderate COVID-19 | Reuters
A source with the Drug Controller General of India said the pill has not shown "significant efficacy" against moderate COVID-19, though it was having success against mild cases.

Comments

Popular posts from this blog

My current Facebook diatribe

» Dear Helen: From One American Lebanese Journalist To another… - Big Journalism